Urinary Incontinence

• Stress incontinence — leakage with coughing, laughing or exertion, from urethral hypermobility or intrinsic sphincter deficiency, commonly after vaginal delivery or with pelvic floor weakness. There is no urge and the post-void residual is normal. First-line management is pelvic floor muscle training, with pessaries or a midurethral sling thereafter.
• Urgency incontinence (overactive bladder) — a sudden compelling urge followed by leakage, from detrusor overactivity. Treated with bladder training first, then antimuscarinics (oxybutynin, tolterodine — with anticholinergic burden a real concern in older adults) or the beta-3 agonist mirabegron.
• Mixed incontinence combines both and is common.
• Overflow incontinence — continuous dribbling from an underfilled-emptying, distended bladder, with a raised post-void residual, from detrusor underactivity (diabetic or other neuropathy) or obstruction (benign prostatic hyperplasia). Antimuscarinics would make this worse.
• Functional incontinence — the urinary tract works, but mobility or cognition prevents reaching the toilet.
• A post-void residual is the single most useful early test, because it separates overflow from the rest.

Sphincteric/support failure (stress)

• Obstetric injury: vaginal delivery, forceps, prolonged second stage and macrosomia stretch the pudendal nerve and tear the endopelvic fascia/levator ani, producing urethral hypermobility.
• Hypoestrogenism: menopause thins the urethral mucosa and submucosal vascular plexus, contributing to intrinsic sphincter deficiency (a component of genitourinary syndrome of menopause).
• Prior pelvic surgery or radiation: scarring and denervation of the urethral sphincter; in men, post-prostatectomy incontinence is the classic example.

Detrusor overactivity (urgency)

• Neurologic disease: stroke, dementia, Parkinson disease and multiple sclerosis remove suprapontine inhibition of the pontine micturition center; spinal cord lesions above the sacral cord produce detrusor–sphincter dyssynergia.
• Local bladder irritation: UTI, stones, or bladder cancer — hematuria in an older smoker with new urgency must not be dismissed as overactive bladder.

Impaired emptying (overflow)

• Obstruction: benign prostatic hyperplasia, urethral stricture, severe pelvic organ prolapse kinking the urethra.
• Detrusor underactivity: diabetic autonomic neuropathy, cauda equina/conus lesions, prior pelvic surgery, and drugs (anticholinergics, opioids, alpha-agonists, calcium channel blockers).

• Stress incontinence: the urethra normally rests on a hammock of endopelvic fascia and levator ani, so a cough compresses it against a firm backboard and transmits abdominal pressure to the urethra as well as the bladder. When childbirth or pudendal neuropathy weakens that support, the urethra descends (urethral hypermobility) and the pressure spike reaches the bladder only — leakage is brief, small-volume, and exactly synchronous with the cough. In intrinsic sphincter deficiency the urethra may be immobile but the sphincter itself cannot coapt, so leakage occurs at minimal provocation and is typically more severe.
• Urgency incontinence: filling normally generates afferent signals that the pontine micturition center holds in check under frontal cortical inhibition. Loss of that inhibition (stroke, dementia) or upregulated bladder afferent C-fibers and spontaneous myocyte activity produce uninhibited detrusor contractions at low volumes. Because the contraction is a coordinated detrusor event mediated by M3 muscarinic receptors, the patient perceives an overwhelming urge and then loses a large volume — the key not in the lock leak.
• Overflow incontinence: chronic obstruction first causes detrusor hypertrophy and trabeculation, then decompensation; alternatively autonomic neuropathy denervates the detrusor outright. Either way the bladder fills far beyond capacity, intravesical pressure passively creeps above outlet resistance, and urine dribbles continuously. The residual volume is high, which is why an antimuscarinic — which further paralyzes an already failing detrusor — precipitates frank retention.
• Fistula (vesicovaginal): urine bypasses the sphincter entirely, giving continuous painless leakage day and night regardless of position or provocation.

Stress incontinence

• Leakage with cough, sneeze, laughing, lifting or exercise, small volume, stopping when the provocation stops — the pressure transient is the entire event.
• No nocturia and no urge, because supine rest removes the abdominal pressure spike.
• Exam: leakage seen at the meatus during a cough stress test with a comfortably full bladder; often coexisting cystocele or anterior wall prolapse; a positive Q-tip test (urethral axis deflecting markedly with straining) indicates urethral hypermobility.

Urgency incontinence

• Sudden compelling urge followed by large-volume leakage, classically triggered by running water, cold, or arriving at the front door (latchkey urgency).
• Frequency and nocturia accompany it, since the uninhibited contractions occur regardless of posture.
• Exam is usually normal; look for the neurologic clue (prior stroke, tremor and bradykinesia, internuclear ophthalmoplegia).

Overflow incontinence

• Continuous or intermittent dribbling, hesitancy, weak stream, straining, incomplete emptying, and a suprapubically palpable/percussible distended bladder.
• Diminished perineal sensation, absent bulbocavernosus reflex or saddle anesthesia points to a sacral/cauda equina lesion; an enlarged prostate on digital rectal exam points to obstruction.

Initial evaluation (office-based, sufficient for the uncomplicated patient)

• History plus a 3-day voiding diary: records volumes, fluid and caffeine intake, leak episodes and their triggers — it distinguishes stress from urgency more reliably than a single description and quantifies nocturnal polyuria.
• Urinalysis with culture if indicated: mandatory first test to exclude UTI, glycosuria, and hematuria. Persistent hematuria without infection requires cystoscopy and upper-tract imaging for malignancy.
• Post-void residual by bladder ultrasound or in-and-out catheter: the pivotal branch point. A residual generally above roughly 150 mL is considered elevated and points to overflow/impaired emptying; thresholds vary and a single measurement should be repeated.
• Pelvic examination for atrophy, prolapse, and pelvic floor strength; cough stress test with a full bladder — visualized leak coincident with the cough is essentially diagnostic of stress incontinence.
• Serum glucose, calcium and renal function when polyuria or neuropathy is suspected.

Confirmatory/specialized testing

• Multichannel urodynamics is the reference standard, measuring detrusor pressure against volume: uninhibited detrusor contractions during filling confirm detrusor overactivity, while leakage at a defined abdominal leak point pressure with no detrusor contraction confirms stress incontinence; low leak point pressure or low maximal urethral closure pressure suggests intrinsic sphincter deficiency.
• Per the AUA/SUFU stress incontinence guideline, urodynamics is not required before a midurethral sling in the straightforward index patient with clear stress symptoms, a positive cough stress test, and a normal residual. Reserve it for mixed or unclear symptoms, prior anti-incontinence surgery, high residual, neurogenic disease, or significant prolapse.
• Cystoscopy for hematuria, suspected fistula, foreign body or mesh erosion; dye testing (oral phenazopyridine or retrograde bladder instillation with a vaginal tampon) helps localize a suspected vesicovaginal fistula.

Behavioral therapy — first-line for every subtype (AUA/SUFU and ACOG)

• Pelvic floor muscle training (Kegel exercises), ideally supervised or with biofeedback, is first-line for stress and mixed incontinence.
• Bladder training with timed voiding and urge suppression is first-line for urgency incontinence; add weight loss, caffeine and alcohol reduction, and fluid management.

Stress incontinence escalation

• Continence pessary or urethral insert for patients declining surgery or awaiting it.
• Midurethral synthetic sling is the standard surgical option per AUA/SUFU; alternatives include autologous fascial pubovaginal sling, Burch colposuspension, and urethral bulking agents for intrinsic sphincter deficiency with a non-mobile urethra.
• No drug is FDA-approved for stress incontinence in the United States; duloxetine is used in some countries but not approved for this indication here.

Urgency incontinence pharmacotherapy (second-line)

• Antimuscarinics (oxybutynin, tolterodine, solifenacin, darifenacin) block detrusor M3 receptors. The AGS Beers Criteria discourage oxybutynin and high anticholinergic burden in older adults given delirium and dementia-risk associations.
• Beta-3 adrenergic agonists (mirabegron, vibegron) relax the detrusor during filling and avoid anticholinergic effects; monitor blood pressure with mirabegron.
• Topical vaginal estrogen for coexisting genitourinary syndrome of menopause; systemic estrogen is not a treatment and may worsen incontinence.

Of the disease

• Perineal dermatitis, maceration and pressure ulceration: chronic ammoniacal urine contact breaks down skin; look for erythema with satellite lesions if Candida has supervened.
• Recurrent urinary tract infection: incomplete emptying leaves a residual culture medium; high residuals also predispose to struvite stones.
• Falls and hip fracture from rushing to the toilet at night — a leading cause of morbidity in older adults and a frequently tested downstream harm of nocturia.
• Social isolation, depression, sexual dysfunction, and caregiver burden driving nursing home placement.
• Obstructive uropathy — an emergency: chronic retention transmits pressure to the upper tracts, causing bilateral hydronephrosis and post-obstructive renal failure. Suspect it with a palpable bladder, rising creatinine and hyperkalemia; catheterize, then watch for post-obstructive diuresis with volume depletion and electrolyte loss.

Of treatment

• Antimuscarinic toxicity: dry mouth, constipation, blurred vision, and in older adults delirium and cognitive decline. Acute angle-closure glaucoma — a painful red eye with a fixed mid-dilated pupil and haloes — is an ophthalmologic emergency. Acute urinary retention may be precipitated, particularly in men with BPH.
• Mirabegron: hypertension and drug interactions via CYP2D6 inhibition.
• Intradetrusor onabotulinumtoxinA: elevated post-void residual and retention requiring clean intermittent catheterization, plus UTI; patients must accept this possibility before injection.
• Midurethral sling: de novo urgency, voiding dysfunction/obstruction, bladder perforation, groin pain, and vaginal mesh exposure or erosion presenting with discharge, bleeding, or dyspareunia (hispareunia in the partner).
• Indwelling catheters: catheter-associated UTI, urosepsis, and long-term squamous cell carcinoma of the bladder — avoid as a management strategy.

• Post-void residual is the single best next step when the history is ambiguous or the patient has diabetes, BPH, or continuous dribbling. It isolates overflow, and overflow is the one subtype where antimuscarinics cause harm.
• Cough stress test positive + normal residual = stress incontinence. No urodynamics is needed before a midurethral sling in this uncomplicated index patient per AUA/SUFU — "order urodynamics" is the classic distractor.
• Pelvic floor muscle training is first-line for stress incontinence and bladder training for urgency, always before drugs or surgery. Weight loss is a genuine, trial-supported intervention in obese women with stress leakage.
• Continuous painless leakage after a hysterectomy or obstructed labor is a vesicovaginal fistula, not urgency incontinence — confirm with dye testing or cystoscopy, and repair it.
• Avoid oxybutynin in older adults (AGS Beers Criteria, anticholinergic burden and delirium); reach for a beta-3 agonist such as mirabegron instead, but check the blood pressure.
• Urgency incontinence after a stroke or in Parkinson disease reflects loss of cortical inhibition over the pontine micturition center — the one neuro–urology association examiners repeatedly test.
• Sudden new incontinence in a hospitalized older patient is transient until proven otherwise — run DIAPPERS and look for delirium, infection, fecal impaction, or a new diuretic before labeling it overactive bladder.
• Refractory urgency after behavioral therapy plus one or two drugs goes to third-line therapy: intradetrusor onabotulinumtoxinA, sacral neuromodulation, or percutaneous tibial nerve stimulation — and counsel that botulinum toxin may require clean intermittent catheterization.
• Hematuria without infection in an older smoker with new urgency is bladder cancer until cystoscopy and imaging say otherwise.